Preclinical findings showed that EIN significantly reduced tumor volume (P < 0.05) and preserved the integrity of the intestinal mucosal barrier, evidenced by higher ZO-1 and Occludin expression (P < 0.05). Here, TJP1 is linked to neoplasm.